LAVA Therapeutics NV (LVTX)
2.67
-0.09
(-3.26%)
USD |
NASDAQ |
May 17, 16:00
2.67
0.00 (0.00%)
After-Hours: 20:00
LAVA Therapeutics Total Assets (Quarterly): 101.71M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.71M |
| September 30, 2023 | 111.02M |
| June 30, 2023 | 122.54M |
| March 31, 2023 | 135.28M |
| December 31, 2022 | 143.42M |
| September 30, 2022 | 149.89M |
| June 30, 2022 | 115.31M |
| Date | Value |
|---|---|
| March 31, 2022 | 129.51M |
| December 31, 2021 | 139.25M |
| September 30, 2021 | 151.04M |
| June 30, 2021 | 160.57M |
| March 31, 2021 | 161.35M |
| December 31, 2020 | 20.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
20.49M
Minimum
Dec 2020
161.35M
Maximum
Mar 2021
126.26M
Average
135.28M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| uniQure NV | 770.05M |
| ProQR Therapeutics NV | 133.77M |
| Merus NV | 498.08M |
| argenx SE | -- |
| Pharming Group | 441.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 50.53M |
| Shareholders Equity (Quarterly) | 51.18M |
| Debt to Equity Ratio | 0.1032 |
| Current Ratio | 6.619 |
| Net Debt Paydown Yield | -0.53% |